本试验为美国癌症委员会标准确定为可切除性Ⅲ、Ⅳ期头颈部鳞癌施行放化疗结合与单纯放疗比较的Ⅲ期随机试验结果。作者将 1 0 0例头颈部鳞癌患者随机分为两组 ,其中一组单纯接受放疗 (ＡｒｍＡ) ,总剂量 60Ｇｙ～ 72Ｇｙ ,每日分割量为 1 .8Ｇｙ～ 2 .0Ｇｙ ;另外一组接受相同 This test for the United States National Cancer Council criteria for the resectability of stage Ⅲ, Ⅳ head and neck squamous cell carcinoma of the radiotherapy and chemotherapy combined with radiotherapy alone compared to the phase Ⅲ randomized trial results. The authors randomized 100 patients with squamous cell carcinoma of the head and neck into two groups. One of the patients received radiotherapy alone (ArmA) at a total dose of 60 Gy to 72 Gy with daily divisions of 1.8 Gy to 2.0 Gy. The other group Accept the same